Skip to main content
Caplight Logo









iDonate

iDonate

Private
Dallas, TexasEnterprise Softwarehttps://idonate.com

Last Round

Series B

Dec 14, 2021

Total Funding Raised

$28.7M

Company Overview

iDonate operates in Enterprise Software and is based in Dallas, Texas. Its latest recorded funding round was a Series B round in December 2021.

iDonate is a software company that provides a digital fundraising platform for nonprofit organizations to optimize online giving and donor engagement.

Sector

Enterprise Software

Verticals

Vertical SaaS, Digital Payments, Workflow Automation

Business Model

B2B

Customer Profile

Payment Processing Fee, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

iDonate Comparables

Compare iDonate with similar companies based on industry and business-model similarity.

iDonate comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Funraise
87%
Givebutter
85%
Fundraise Up
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

iDonate Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 14, 2021
VC RoundFeb 11, 2020
Series AOct 3, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

iDonate Investors

Notable investors and investment history

iDonate investors
InvestorRounds
MissionOGSeries B
PerformanceEdge PartnersSeries B, VC Round, Series A
The Miles FoundationSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 21, 2025

    Title sponsor of the Nonprofit Innovation & Optimization Summit.

Book a demo to see all signals

For institutional investors. Book with your work email.

iDonate Filings

Explore SEC and related filing metadata, where available.

iDonate filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about iDonate's valuation, stock price, and market status.

Is iDonate a public or private company?

iDonate is a private company.

What is the current stock price of iDonate?

iDonate is a private company, so its shares have no public market price. Caplight tracks iDonate's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is iDonate worth (valuation)?

Valuation information for iDonate is not publicly available.

Can I buy iDonate stock?

iDonate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was iDonate's last funding round?

iDonate's most recent funding round was Series B on December 14, 2021.

Who are the main investors in iDonate?

Key investors in iDonate include MissionOG, PerformanceEdge Partners.

Will iDonate IPO soon?

No public IPO plans have been announced for iDonate.

How can I track iDonate secondary market activity?

Caplight tracks bids, offers, and trades in iDonate's shares on secondary markets.

Firmographic Details

HeadquartersDallas, Texas
Employee Range24
Year Founded2010
Last FundingDec 14, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?